A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick, New Jersey, United States

NEXT Oncology ( Site 0051), Irving, Texas, United States

NEXT Virginia ( Site 0054), Fairfax, Virginia, United States

Blacktown Hospital ( Site 0455), Sydney, New South Wales, Australia

Monash Health ( Site 0452), Clayton, Victoria, Australia

The Alfred Hospital ( Site 0453), Melbourne, Victoria, Australia

One Clinical Research ( Site 0454), Nedlands, Western Australia, Australia

Princess Margaret Cancer Centre ( Site 0001), Toronto, Ontario, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0002), Québec, Quebec, Canada

Pontificia Universidad Catolica de Chile-CICUC ( Site 0103), Santiago, Region M. de Santiago, Chile

Bradfordhill ( Site 0102), Santiago, Region M. de Santiago, Chile

Rambam Health Care Campus ( Site 0252), Haifa, Israel

Rabin Medical Center ( Site 0253), Petah Tikva, Israel

Sheba Medical Center ( Site 0251), Ramat Gan, Israel

Seoul National University Hospital ( Site 0501), Seoul, South Korea

Asan Medical Center ( Site 0502), Seoul, South Korea

Hospital General Universitari Vall d Hebron ( Site 0360), Barcelona, Spain

Hospital Clinic de Barcelona ( Site 0362), Barcelona, Spain

Hospital Universitario Fundacion Jimenez Diaz ( Site 0361), Madrid, Spain